However, new therapies for Gaucher Disease are being developed, such as gene therapy and therapy with glucocerebrosidase inhibitors, which may provide additional therapeutic options for patients with Gaucher Disease (Jaffe et al., 2019; Koppe et al., 2016; Leonart et al., 2023). Here, GBA1 is linked to Gaucher disease.